Study Details
A Study of ASP8302 in participants with Underactive Bladder
Clinicaltrials.gov ID
Astellas Study ID
8302-CL-0201
EudraCT ID
2017-003693-13
Condition
Underactive Bladder
Phase
Phase 2
Age
18 years - N/A
Sex
Female & Male
Product
ASP8302
Type
Interventional
Trial Dates
Nov 2018 - Apr 2020
Masking
Double (Participant, Investigator)
Enrollment number
135
A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 2a, Proof-of-Concept Study of ASP8302 in Subjects with Underactive Bladder
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A Study of ASP8302 in participants with Underactive Bladder? Contact us by filling our your information to the right and we’ll respond to you.
Locations
Site DE49001
Duisburg, Germany
Site NL31004
Zwolle, Netherlands
Site JP81013
Shizuoka, Japan
Site DE49002
Duisburg, Germany
Site JP81015
Sapporo, Japan
Site SK42101
Nitra, Slovakia
Site NL31002
Maastricht, Netherlands
Site JP81012
Kurashiki, Japan
Site JP81008
Obu, Japan
Site UK44002
Bristol, United Kingdom
Site JP81001
Shimotsuga-gun, Japan
Site SK42103
Kosice, Slovakia
Site JP81010
Saga, Japan
Site UK44003
Cambridge, United Kingdom
Site DE49004
Gronau, Germany
Site PL48004
Myslowice, Poland
Site PL48002
Szczecin, Poland
Site UK44001
Sheffield, United Kingdom
Site DE49003
Moenchengladbach, Germany
Site JP81002
Kobe, Japan
Site JP81006
Asahikawa, Japan
Site JP81009
Nagoya, Japan
Site PL48001
Warsaw, Poland
Site JP81004
Kumamoto, Japan
Site PL48003
Piaseczno, Poland
Site JP81011
Osakasayama, Japan
Site NL31003
Eindhoven, Netherlands
Site JP81005
Sapporo, Japan
Site SK42102
Trencin, Slovakia
Site JP81003
Fukuoka, Japan
Site JP81007
Yoshida-gun, Japan
Site NL31001
Rotterdam, Netherlands